{"id":"W2765735024","doi":"10.2174/1874312901711010123","title":"Dose Escalation and Co-therapy Intensification Between Etanercept, Adalimumab, and Infliximab: The CADURA Study","year":2017,"lang":"en","type":"article","venue":"The Open Rheumatology Journal","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Clinical Research Institute; Credit Valley Hospital; Amgen (Canada); Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke; Southlake Regional Health Center","funders":"Amgen","keywords":"Medicine; Adalimumab; Infliximab; Etanercept; Internal medicine; Rheumatoid arthritis; De-escalation; Retrospective cohort study; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.002157951,0.0001616735,0.0004283707,0.00007171424,0.002546016,0.0009370315,0.0006630505,0.00007692557,0.0001019787],"category_scores_gemma":[0.0003774593,0.00008186887,0.00003978673,0.00004270034,0.0009183792,0.0004316613,0.0002459971,0.0006536776,0.00001912603],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002119465,"about_ca_system_score_gemma":0.0001017691,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004606427,"about_ca_topic_score_gemma":0.00009917247,"domain_scores_codex":[0.9983546,0.000473237,0.0004014563,0.00021314,0.0002761145,0.0002814332],"domain_scores_gemma":[0.9983439,0.0003070539,0.0003587255,0.0006328509,0.0001939178,0.0001635166],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008572404,0.0001106198,0.8610818,0.000006285303,0.0003866031,0.00002981945,0.00741288,3.079072e-7,0.0003801603,0.0006671592,0.001069934,0.1279972],"study_design_scores_gemma":[0.006956991,0.0005991919,0.9765779,0.0001099282,0.00001777538,0.004610945,0.005078462,0.00009203759,0.00008516925,0.001764386,0.00399504,0.0001121765],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9773262,0.002702343,0.00003288819,0.01803871,0.00008192705,0.001068554,0.000003144918,0.00001215347,0.0007341297],"genre_scores_gemma":[0.9763984,0.0231404,0.00006287391,0.000164637,0.00004198315,0.00002992713,0.000004324894,0.00001926984,0.0001381849],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1278851,"threshold_uncertainty_score":0.9987525,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08422064680375173,"score_gpt":0.399561123297553,"score_spread":0.3153404764938013,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}